Staging and management of cutaneous T-cell lymphoma

Clinical and Experimental Dermatology

Volumn 31, Issue 2, 2006, Pages 181-186

  Scarisbrick, J J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BEXAROTENE; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DEPSIPEPTIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GAMMA INTERFERON; GEMCITABINE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 12; LIPID; METHOTREXATE; MONOCLONAL ANTIBODY; OKT 4; PENTOSTATIN; PREDNISONE; PSORALEN; RETINOID X RECEPTOR AGONIST; T LYMPHOCYTE RECEPTOR; THYROXINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ALOPECIA; ARTHRALGIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAPILLARY LEAK SYNDROME; CLINICAL EXAMINATION; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG TOLERABILITY; EARLY CANCER; ECZEMA; ELECTRON THERAPY; ENTERITIS; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFECTION; LIPID BLOOD LEVEL; LYMPH NODE METASTASIS; MAINTENANCE THERAPY; MONOTHERAPY; MORBIDITY; MYCOSIS FUNGOIDES; PHOTOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PUVA; RADIATION DOSE; RECEPTOR GENE; REVIEW; SEPTICEMIA; SEZARY SYNDROME; SIDE EFFECT; SINGLE DRUG DOSE; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CANCER; SKIN EXAMINATION; SOUTHERN BLOTTING; STEM CELL TRANSPLANTATION; SURVIVAL TIME; SYSTEMIC THERAPY; T CELL DEPLETION; TELANGIECTASIA; THYROXINE BLOOD LEVEL; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; WHOLE BODY RADIATION; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; DERMATOLOGIC AGENTS; HUMANS; IMMUNOTHERAPY; LYMPHOMA, T-CELL, CUTANEOUS; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PHOTOPHERESIS; PHOTOTHERAPY; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 33645059716     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.02019.x     Document Type: Review

References (33)

1. Harris NL Jaffe ES Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84 1361 92
2. Willemze R Kerl H Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer Blood 1997 90 354 71
3. Jaffes ES Harris NL Stein H et al. World Health Organisation classification of tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
4. Willemze R Jaffe ES Burg G et al. WHO-EORTC classification for cutaneous lymphomas Blood 2005 105 3768 85
5. Lamberg SI Bunn PA Jr. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group National Cancer Institute Workshop Arch Dermatol 1979 115 1103 5
6. Whittaker SJ Joint BAD & UKCLG guidelines for CTCL Br J Dermatol 2003 149 1095 107
7. Scarisbrick JJ Whittaker S Evans AV et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma Blood 2001 97 624 30
8. Fraser-Andrews EA Woolford AJ Russell-Jones R et al. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides J Invest Dermatol 2000 114 117 21
9. Whittaker SJ Marsden JR Spittle M Russell Jones R British Association of Dermatologists, U.K., Cutaneous Lymphoma Group, Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas Br J Dermatol 2003 149 1095 107
10. Bachelez H Bioul L Flageul B et al. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sezary syndrome Arch Dermatol 1995 131 1027 31
11. Kaye FJ Bunn PA Jr. Steinberg SM et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides N Engl J Med 1989 321 1784 90
12. Hoppe RT Abel EA Deneau DG Price NM Mycosis fungoides: Management with topical nitrogen mustard J Clin Oncol 1987 5 1796 803
13. Zackheim HS Topical carmustine (BCNU) in the treatment of mycosis fungoides Dermatol Ther 2003 16 299 302
14. Breneman D Duvic M Kuzel T et al. Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma Arch Dermatol 2002 138 325 32
15. Herrmann JJ Roenigk HH Jr. Hurria A et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up J Am Acad Dermatol 1995 33 234 42
16. Rosenbaum MM Roenigk HH Jr. Caro WA Esker A Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients J Am Acad Dermatol 1985 13 613 22
17. Scarisbrick JJ Child FJ Evans AV et al. Secondary malignant neoplasms in 71 patients with Sezary syndrome Arch Dermatol 1999 135 1381 5
18. Hoppe RT Total skin electron beam therapy in the management of mycosis fungoides Front Radiat Ther Oncol 1991 25 132 3
19. Jones GW Rosenthal D Wilson LD Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome) Cancer 1999 85 1985 95
20. Edelson R Berger C Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results N Engl J Med 1987 316 297 303
21. Gottlieb SL Wolfe JT Fox FE et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution J Am Acad Dermatol 1996 35 946 57
22. Child FJ Mitchell TJ Whittaker SJ et al. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides Clin Exp Dermatol 2004 29 231 6
23. Olsen EA Rosen ST Vollmer RT et al. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma J Am Acad Dermatol 1989 20 395 407
24. Bunn PA Jr. Ihde DC Foon KA The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas Cancer 1986 57 1689 95
25. Roenigk HH Jr. Kuzel TM Skoutelis AP et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma J Invest Dermatol 1990 95 198 205S
26. Lundin J Osterborg A Brittinger G et al. CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma J Clin Oncol 1998 16 3257 63
27. Olsen E Duvic M Frankel A et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma J Clin Oncol 2001 19 376 88
28. Talpur R Ward S Apisarnthanarax N et al. Optimizing bexarotene therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 2002 47 672 84
29. Bunn PA Jr. Hoffman SJ Norris D et al. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome) Ann Intern Med 1994 121 592 602
30. q10 Bigler RD Crilley P Micaily B et al. Autologous bone marrow transplantation for advanced stage mycosis fungoides Bone Marrow Transplant 1991 7 133 7
31. Russell-Jones R Child F Olavarria E et al. Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival Ann NY Acad Sci 2001 941 147 54
32. Oyama Y Guitart J Kuzel TM et al. High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma Hematol Oncol Clin North Am 2003 17 1475 83
33. Piekarz RL Robey R Sandor V et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report Blood 2001 98 2865 8